Dacarbazine (DIC) clinical pharmacology: effects of intensive Corynebacterium parvum (CP) immunotherapy and actinomycin D (ACT D)

S. W. Hall, R. S. Benjamin, J. U. Gutterman

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

@article{f66918de27f941fd869bb56dfa227f85,

title = "Dacarbazine (DIC) clinical pharmacology: effects of intensive Corynebacterium parvum (CP) immunotherapy and actinomycin D (ACT D)",

author = "Hall, {S. W.} and Benjamin, {R. S.} and Gutterman, {J. U.}",

year = "1977",

language = "English (US)",

volume = "19",

pages = "No. 619",

journal = "Pharmacologist",

issn = "0031-7004",

number = "2",

}

TY - JOUR

T1 - Dacarbazine (DIC) clinical pharmacology

T2 - effects of intensive Corynebacterium parvum (CP) immunotherapy and actinomycin D (ACT D)

AU - Hall, S. W.

AU - Benjamin, R. S.

AU - Gutterman, J. U.

PY - 1977

Y1 - 1977

UR - http://www.scopus.com/inward/record.url?scp=17344382456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17344382456&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:17344382456

SN - 0031-7004

VL - 19

SP - No. 619

JO - Pharmacologist

JF - Pharmacologist

IS - 2

ER -